We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies. Close

Advanced Search

Advanced

Law Reports

Pharmaceutical Law Insight

: Dear Subscriber,; Online Published Date : 10 June 2010 | Appeared in issue: Vol 6 No 5 - 01 May 2010; I would like to inform you of an exciting change to your Pharmaceutical Law Insight subscription which will give you even more valuable content at no extra cost. This current issue (May 2010) will be the last stand-alone issue of Pharmaceutical Law..

: News in brief; Online Published Date : 10 June 2010 | Appeared in issue: Vol 6 No 5 - 01 May 2010; AstraZeneca settles generic Entocort suit UNITED STATES Anglo-Swedish drug maker AstraZeneca has reached a settlement with Teva Pharmaceuticals over the marketing of a generic copy of AstraZeneca’s anti-inflammatory drug Entocort (budesonide)...

: US court wants clarification on pay-to-delay settlements; Online Published Date : 10 June 2010 | Appeared in issue: Vol 6 No 5 - 01 May 2010; The US Court of Appeals has called on the District Court to revisit a 2005 decision which set the legal precedent to allow so-called ‘pay-to-delay’ deals within the pharmaceutical industry. These deals involve patent-owning..

: News in brief; Online Published Date : 10 June 2010 | Appeared in issue: Vol 6 No 5 - 01 May 2010; Merck settles Zetia patent suit UNITED STATES Merck & Co has settled its patent litigation against generic drug firm Glenmark Pharmaceuticals over Merck’s cholesterol lowering drug Zetia (ezetimibe). The case was set to go to trial on 12..

: Report warns of critical time for pharma patents; Online Published Date : 10 June 2010 | Appeared in issue: Vol 6 No 5 - 01 May 2010; A looming patent cliff facing major pharmaceutical companies is pushing the industry into a critical phase in terms of drug innovation and consolidation, according to the latest annual life sciences research from IP law firm Marks & Clerk. The..

: The influence of the Draft Amendment to the Patent Act on biotech patents in Taiwan; Online Published Date : 10 June 2010 | Appeared in issue: Vol 6 No 5 - 01 May 2010; Patent Attorneys Yulan Kuo and Frank Lu explore the possibilities of patenting animal and plant subject-matters in Taiwan

: Pharmaceutical patents case clarifies first authorisation; Online Published Date : 10 June 2010 | Appeared in issue: Vol 6 No 5 - 01 May 2010; Supplementary Protection Certificate appeal dismissed on reference to European case law

: Pharmaceutical trademarks in the European Union; Online Published Date : 10 June 2010 | Appeared in issue: Vol 6 No 5 - 01 May 2010; Mary Spears, attorney at HGF, discusses the special considerations to be taken into account when applying for pharmaceutical trademarks within the EU

: ECJ says rules limiting pharmacies are justified; Online Published Date : 10 June 2010 | Appeared in issue: Vol 6 No 5 - 01 May 2010; EU member states are free to limit the establishment of new pharmacies by geographic and demographic considerations as long as they are not discriminatory in applying those rules or prevent the adequate provision of pharmaceutical..

: Patent litigation and doctrine of equivalents; Online Published Date : 10 June 2010 | Appeared in issue: Vol 6 No 5 - 01 May 2010; Maria Nilova, managing partner of law firm PATENTICA, discusses the enforcement of IP rights in Russia

: News in brief; Online Published Date : 10 June 2010 | Appeared in issue: Vol 6 No 5 - 01 May 2010; German court invalidates GSK Advair patent GERMANY A group of generic drug makers have won a patent challenge in a German court against GlaxoSmithKline’s asthma drug Advair (fluticasone/salmeterol). The German Federal Patents Court ruling..